Welcome to the Other Digestive System Studies Page

CURRENT STUDIES THAT MAY INTEREST YOU


Irritable Bowel Syndrome with Constipation Study – Children Ages 7-17

Does your child aged 7-17 struggle with constipation and abdominal pain? If so, your child may be able to take part in a research study to find out if an investigational drug is safe and effective for children with Irritable Bowel Syndrome with Constipation (IBS-C). Reimbursement may be provided.

Age Range
AGE:   7 - 17

Duration DURATION:  9-12 weeks
VISITS:  6 visits
Location LOCATION:  Children’s Hospital of Pittsburgh of UPMC - 4401 Penn Ave, Pittsburgh, PA 15224


Biliary Atresia Study

Is your child between 6 months and 17 years old with a diagnosis of biliary atresia? Has your child had the Kasai procedure (surgery to improve bile flow)? If so, your child may be able to participate in a research study to learn more about the long term health of patients who have had the Kasai procedure. Participation by parents is voluntary. Compensation for transportation provided.

Age Range
AGE:   0 - 17

Duration DURATION:  Varies
Location LOCATION:  UPMC Children’s Hospital of Pittsburgh - Lawrenceville


LOGIC Study for Children with Cholestatic Liver Disease

Are you the parent of a child with diagnosed or suspected cholestatic liver disease? Children between the ages of 0-17 may be able to participate in a research study to learn more about the causes and long-term effects of certain cholestatic liver diseases. Compensation provided.

Age Range
AGE:   0 - 17

Duration DURATION:  10 years
VISITS:  1 visit per year
Location LOCATION:  UPMC Children’s Hospital of Pittsburgh


INSPPIRE Study

Researchers are conducting a study at Children’s Hospital of UPMC that aims to develop a database of children with acute, acute recurrent or chronic pancreatitis to better understand the causes and treatments of the disease. The study involves a physical exam, family history and you may be contacted in the future for additional studies.

Age Range
AGE:   0 - 17


Alpha-1 Study – Ages 14-17

If your child has Alpha-1-Antitrypsin deficiency (ATD) and liver disease, he or she may be able to participate in a research study to find out if the drug carbamazepine (Tegretol®) can help to prevent or treat liver disease in people with ATD. Participants receive carbamazepine or a placebo for one year. Travel expenses compensated.

Age Range
AGE:   14 - 17

Duration VISITS:  7 visits in a little over 1 year
Location LOCATION:  UPMC Children’s Hospital of Pittsburgh



RELATED RESEARCH AREAS:
  Digestive System

Pitt+Me

 
OUR PRIVACY POLICY
 

Remember, your personal information is kept confidential, and participation in research is always voluntary.

 
FacebookFacebook     TwitterTwitter     YouTubeYouTube    
 
CTSI.PITT.EDU

This website is maintained by the Clinical and Translational Science Institute.
© Copyright 2018, University of Pittsburgh. All rights reserved.

PITT.EDU